Table 3 MVMR analysis between CHB and the COVID-19 outcomes

BMI

Susceptibility

0.381

0.115

1.46 (1.17–1.84)

9.64E−04

Basophil count

Susceptibility

0.092

0.096

1.10 (0.91–1.32)

3.42E−01

Smoking behaviors

Susceptibility

2.92

0.834

18.55 (3.62–95.03)

4.59E−04

CHB

Susceptibility

0.063

0.02

1.06 (1.02–1.11)

1.44E−03

Type 2 diabetes

Susceptibility

0.079

0.034

1.08 (1.01–1.16)

2.12E−02

BMI

Hospitalization

0.679

0.135

1.97 (1.51–2.57)

4.91E−07

Basophil count

Hospitalization

0.008

0.114

1.01 (0.81–1.26)

9.47E−01

Smoking behaviors

Hospitalization

2.383

0.987

10.84 (1.57–74.98)

1.57E−02

CHB

Hospitalization

0.11

0.022

1.12 (1.07–1.16)

5.13E−07

Type 2 diabetes

Hospitalization

0.141

0.041

1.15 (1.06–1.25)

5.77E−04

BMI

Severity

1.091

0.27

2.98 (1.75–5.06)

5.45E−05

Basophil count

Severity

− 0.372

0.226

0.69 (0.44–1.07)

1.00E−01

Smoking behaviors

Severity

− 0.337

1.996

0.71 (0.01–35.71)

8.66E−01

CHB

Severity

0.11

0.05

1.12 (1.01–1.23)

2.90E−02

Type 2 diabetes

Severity

0.234

0.081

1.26 (1.08–1.48)

3.67E−03